69 search results for: disease control

Adult Asthma Interactive Patient Cases
interactivity

Adult Asthma Interactive Patient Cases

Pulmonology
Explore 3 hypothetical patient cases using guideline-based checklists for assessment and diagnosis of type 2 inflammation in adult asthma
View more
What treatments may be needed to achieve remission? And In what percentage of patients could remission be a target?
expert video

What treatments may be needed to achieve remission? And In what percentage of patients could remission be a target?

Rhinology
Prof. Hellings and Prof. Corso highlight that disease severity plays a key role in rate and control of remission in CRS.
View more
IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP
expert video

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Rhinology
Prof. Joaquim Mullol presents on the proposed mechanisms of smell loss and nasal congestion in CRSwNP.
View more
Connecting Type 2 Inflammation to CRSwNP
expert video

Connecting Type 2 Inflammation to CRSwNP

Rhinology
Prof. Claus Bachert describes how type 2 inflammation drives CRSwNP.
View more
EAACI 2023 | Biologics in CRSwNP: Comparative Efficacy and Real-World Effectiveness
expert video

EAACI 2023 | Biologics in CRSwNP: Comparative Efficacy and Real-World Effectiveness

Rhinology
Join Profs. Martin Wagenmann and Eugenio De Corso as they discuss type 2 inflammation in CRSwNP and explore real-world data on biologic efficacy.
View more
Updates in PN and CSU: Emerging Therapeutic Landscapes and Implications for Patient Management
expert video

Updates in PN and CSU: Emerging Therapeutic Landscapes and Implications for Patient Management

Dermatology
A review of disease burden and treatment needs in PN and CSU, and how current and emerging therapies can impact patient management in these respective diseases.
View more
ADVENT On Air - Dermatology
Podcast

ADVENT On Air | Expert Discussions in Dermatology

Dermatology
Listen to the latest updates in type 2 inflammatory science and associated skin diseases, brought to you by leading dermatology experts in the field. ADVENT On Air podcasts feature scientific conversations that explore new research into the pathophysiology, clinical features, and disease burden for a range of dermatological diseases linked to type 2 inflammation, including atopic dermatitis (AD) and prurigo nodularis (PN). Hear new insights revealed through expert-led conversations below or in your preferred podcast app.

View more
Emerging Therapeutic Landscape and Implications for Patient Management in CSU
expert video

Emerging Therapeutic Landscape and Implications for Patient Management in CSU

Dermatology
A review of disease burden and treatment needs in CSU, and how current and emerging therapies can impact patient management.
View more
Emerging Therapeutic Landscape and Implications for Patient Management in PN​
expert video

Emerging Therapeutic Landscape and Implications for Patient Management in PN​

Dermatology
A review of disease burden and treatment needs in PN, and how current and emerging therapies can impact patient management.
View more
UEGW 2023 | Biologics in EoE
expert video

UEGW 2023 | Biologics in EoE

Gastroenterology
Prof. Christoph Schlag presents the latest clinical data for biologics in EoE.
View more
UEGW 2023 | How Do You and Your Patient Decide What Is Best for Managing Their EoE?
expert video

UEGW 2023 | How Do You and Your Patient Decide What Is Best for Managing Their EoE?

Gastroenterology
Prof. Christoph Schlag and Dr. Christopher Ma discuss their approaches to treatment decisions and maintenance therapy for their patients with EoE.
View more
Evaluating the Responses to Biologic Therapies in Children With Atopic Dermatitis
expert video

Evaluating the Responses to Biologic Therapies in Children With Atopic Dermatitis

Dermatology
Dr. Amy Paller shares her opinion on practical considerations for evaluating response during treatment with biologics in children with atopic dermatitis.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: AustriaChange country/region